Senior Clinical Research Associate @ (December 2011 - September 2012)
Senior Clinical Research Associate @ Crucell Biologics (May 2011 - November 2011)
Senior Clinical Research Associate @ (June 2006 - May 2011)
Data Manager and Protocol Monitor @ (October 2005 - June 2006)
Clinical Reasearch Associate III @ Pharmaceutical Product Development, Inc (January 2005 - October 2005)
http: and and www.med.navy.mil and sites and nmrc and Pages and index.htm @ Naval Medical Reseacrh Center (NMRC) (February 1998 - January 2005)
Advanced Laboratory Technologist @ (January 1985 - January 2005)
Christopher Dacosta Education
Naval School of Health Sciences (NSHS)
(Science/Health Care)
1985-1990
San Beda College (St Benedict College)
BS (Commerce / Major in Management)
1980-1984
Christopher Dacosta Skills
Infectious Diseases
Clinical Monitoring
Vaccines
EDC
Biotechnology
Clinical Research
Clinical Trial Management
Regulatory Affairs
Data Management
Protocol Development
ICH-GCP
SOP
Regulatory Submissions
CTMS
Protocol
Clinical Development
GCP
Clinical Trials
Therapeutic Areas
CRO
Clinical Study Design
Clinical Data Management
IRB
FDA
Neurology
Oracle Clinical
Drug Development
Immunology
Pharmaceutical Industry
Patient Recruitment
Clinical Operations
Inform
Trial Management
Medical Writing
Oncology
CRF design
Cardiology
Regulatory Requirements
Hematology
Pharmacovigilance
IND
Medidata
21 CFR Part 11
Drug Safety
Cancer
Endocrinology
Dermatology
Oncology Clinical Research
Microbiology
Christopher Dacosta Summary
Christopher Dacosta, based in Jefferson, MD, US, is currently a Global Study Director at AstraZeneca. Christopher Dacosta brings experience from previous roles at AstraZeneca and MedImmune. Christopher Dacosta holds a 1985 - 1990 Naval School of Health Sciences (NSHS). With a robust skill set that includes Infectious Diseases, Clinical Monitoring, Vaccines, EDC, Biotechnology and more. Christopher Dacosta has 3 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Christopher Dacosta?
Find contact details for 700 million professionals.